CMV-specific T-Cells for Treatment of CMV Infection after Hematopoietic Stem Cell Transplantation in a Pediatric Case: First Application in Turkey

• Sevil Celilova,
• Ersin Toret,
• Başak Adaklı Aksoy,
• Ercüment Ovalı,
• Ceyhun Bozkurt

Affiliations

Sevil Celilova

Altınbaş University Faculty of Medicine, Medicalpark Bahçelievler Hospital, Department of Pediatric Hematology-Oncology & Bone Marrow Transplantation Unit, İstanbul, Turkey

Ersin Toret

Altınbaş University Faculty of Medicine, Medicalpark Bahçelievler Hospital, Department of Pediatric Hematology-Oncology & Bone Marrow Transplantation Unit, İstanbul, Turkey

Başak Adaklı Aksoy

Altınbaş University Faculty of Medicine, Medicalpark Bahçelievler Hospital, Department of Pediatric Hematology-Oncology & Bone Marrow Transplantation Unit, İstanbul, Turkey

Ercüment Ovalı

Acıbadem University Faculty of Medicine, Altunizade Hospital, Department of Hematology, İstanbul, Turkey

Ceyhun Bozkurt

İstinye University Faculty of Medicine, Medicalpark Bahcelievler Hospital, Department of Pediatric Hematology-Oncology & Bone Marrow Transplantation Unit, İstanbul, Turkey